Stephen Locarnini
Director/Miembro de la Junta en BIOTRON LIMITED .
Fortuna: 28 728 $ al 31/05/2024
Cargos activos de Stephen Locarnini
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOTRON LIMITED | Director/Miembro de la Junta | 23/10/2018 | - |
| Independent Dir/Board Member | 23/10/2018 | - | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | - | - |
Historial de carrera de Stephen Locarnini
Antiguos cargos conocidos de Stephen Locarnini.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ClearB Therapeutics, Inc.
 ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Fundador | 01/01/2017 | - |
| Victorian Infectious Diseases Reference Laboratory | Corporate Officer/Principal | 01/01/1990 | - |
| World Health Organization Collaborating Centre | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
| Australia | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOTRON LIMITED | Health Technology |
| Empresas privadas | 3 |
|---|---|
| World Health Organization Collaborating Centre | |
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
| Victorian Infectious Diseases Reference Laboratory |
- Bolsa de valores
- Insiders
- Stephen Locarnini
- Experiencia
